Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.

Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.

The stratification of patients with acute lymphoblastic leukemia (ALL) into treatment risk groups based on quantification of minimal residual disease (MRD) after induction therapy is now well accepted but the relapse rate of about 20% in intermediate risk patients remains a challenge. The purpose of...

Full description

Bibliographic Details
Main Authors: Mawar Karsa, Luciano Dalla Pozza, Nicola C Venn, Tamara Law, Rachael Shi, Jodie E Giles, Anita Y Bahar, Shamira Cross, Daniel Catchpoole, Michelle Haber, Glenn M Marshall, Murray D Norris, Rosemary Sutton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3795712?pdf=render

Internet

http://europepmc.org/articles/PMC3795712?pdf=render

Similar Items